Your browser is no longer supported. Please, upgrade your browser.
Applied Molecular Transport Inc.
Index- P/E- EPS (ttm)-2.42 Insider Own2.00% Shs Outstand38.44M Perf Week-13.96%
Market Cap324.65M Forward P/E- EPS next Y-2.63 Insider Trans-2.45% Shs Float29.31M Perf Month-41.23%
Income-89.20M PEG- EPS next Q-0.66 Inst Own70.30% Short Float7.70% Perf Quarter-63.67%
Sales- P/S- EPS this Y-236.20% Inst Trans-0.03% Short Ratio7.98 Perf Half Y-72.31%
Book/sh4.88 P/B1.64 EPS next Y-2.30% ROA-51.10% Target Price73.00 Perf Year-76.49%
Cash/sh4.51 P/C1.78 EPS next 5Y38.70% ROE-55.70% 52W Range8.22 - 78.22 Perf YTD-42.70%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-89.76% Beta-
Dividend %- Quick Ratio19.30 Sales past 5Y- Gross Margin- 52W Low-2.55% ATR0.95
Employees113 Current Ratio19.30 Sales Q/Q- Oper. Margin- RSI (14)19.36 Volatility11.74% 8.80%
OptionableYes Debt/Eq0.00 EPS Q/Q-40.00% Profit Margin- Rel Volume0.84 Prev Close8.37
ShortableYes LT Debt/Eq0.00 EarningsNov 11 AMC Payout- Avg Volume282.64K Price8.01
Recom1.20 SMA20-29.55% SMA50-44.45% SMA200-73.41% Volume241,463 Change-4.30%
Mar-17-21Initiated JMP Securities Mkt Outperform $92
Jun-30-20Initiated SVB Leerink Outperform $32
Jun-30-20Initiated Jefferies Buy $38
Jun-30-20Initiated BofA Securities Buy $34
Jan-27-22 04:30PM  
Nov-15-21 08:00AM  
Nov-10-21 04:01PM  
Oct-11-21 04:01PM  
Sep-17-21 08:00AM  
Sep-15-21 06:34AM  
Aug-24-21 04:01PM  
Aug-10-21 04:01PM  
Aug-05-21 08:00AM  
Jul-09-21 08:00AM  
Jun-13-21 12:46PM  
Jun-09-21 08:00AM  
May-26-21 08:00AM  
May-13-21 04:01PM  
May-06-21 08:00AM  
Apr-27-21 03:17PM  
Apr-08-21 01:08AM  
Apr-06-21 04:01PM  
Mar-31-21 08:45PM  
Mar-29-21 04:11PM  
Mar-22-21 08:00AM  
Mar-19-21 04:05PM  
Mar-13-21 06:56AM  
Mar-09-21 08:00AM  
Mar-04-21 11:30PM  
Mar-01-21 08:00AM  
Feb-17-21 08:00AM  
Jan-19-21 08:00AM  
Dec-05-20 01:24AM  
Nov-24-20 08:00AM  
Nov-12-20 04:05PM  
Nov-11-20 08:00AM  
Nov-10-20 08:00AM  
Sep-22-20 08:00AM  
Sep-06-20 09:35AM  
Aug-27-20 08:00AM  
Aug-11-20 04:00PM  
Aug-05-20 08:00AM  
Jun-16-20 08:13AM  
Jun-09-20 04:05PM  
Jun-04-20 10:40PM  
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammatory indications. It is also involved in developing AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase Ia clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kanwar BittooChief Medical OfficerDec 22Option Exercise2.3831,50074,97031,500Dec 23 05:50 PM
Mrsny Randall Ph.D.Chief Scientific OfficerDec 09Buy14.993,50052,4643,500Dec 10 04:28 PM
EPIQ Capital Group, LLCManaging member of 10% ownerNov 17Buy22.387,135159,6848,275,375Nov 18 03:41 PM
EPIQ Capital Group, LLCManaging member of 10% ownerNov 16Buy22.574,00090,2988,268,240Nov 18 03:41 PM
Kim Helen SusanDirectorAug 27Sale30.9495129,425575,000Aug 27 08:45 PM
Kim Helen SusanDirectorAug 26Sale30.1614,063424,074575,951Aug 27 08:45 PM
Kim Helen SusanDirectorAug 25Sale30.089,478285,075590,014Aug 25 09:07 PM
Kim Helen SusanDirectorAug 24Sale30.0350815,255599,492Aug 25 09:07 PM
Cross ShawnChief Financial OfficerAug 23Option Exercise4.619,70044,7179,700Aug 23 07:40 PM
Cross ShawnChief Financial OfficerAug 23Sale30.129,700292,1900Aug 23 07:40 PM
Cross ShawnChief Financial OfficerAug 19Option Exercise4.613001,383300Aug 23 07:40 PM
Cross ShawnChief Financial OfficerAug 19Sale30.013009,0030Aug 23 07:40 PM
Bhatt ElizabethChief Bus. & Strategy OfficerJul 21Option Exercise4.619,00041,4909,000Jul 22 07:59 PM
Bhatt ElizabethChief Bus. & Strategy OfficerJul 21Sale36.689,000330,0970Jul 22 07:59 PM
Kanwar BittooChief Medical OfficerJul 07Option Exercise2.387,50017,8507,500Jul 08 07:49 PM
Kanwar BittooChief Medical OfficerJul 07Sale42.097,500315,6930Jul 08 07:49 PM
Kim Helen SusanDirectorJul 02Sale43.32200,0008,663,731600,000Jul 06 07:22 PM
Bhatt ElizabethChief Bus. & Strategy OfficerApr 21Option Exercise4.619,00041,4909,000Apr 22 06:29 PM
Bhatt ElizabethChief Bus. & Strategy OfficerApr 21Sale40.519,000364,5570Apr 22 06:29 PM
Kanwar BittooChief Medical OfficerApr 07Option Exercise2.387,50017,8507,500Apr 08 09:15 PM
Kanwar BittooChief Medical OfficerApr 07Sale54.797,500410,9460Apr 08 09:15 PM
Lamond DavidDirectorApr 06Buy42.0025,0001,050,0001,011,019Apr 07 06:47 PM